Two Sigma Advisers
SPPI

Two Sigma Advisers’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Two Sigma Advisers’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-48,300
Closed -$38K – 2791
2022
Q2 		$38K Sell
48,300
-536,700
-92% -$473K ﹤0.01% 2506
2022
Q1 		$755K Buy
585,000
+196,500
+51% +$181K ﹤0.01% 1787
2021
Q4 		$493K Sell
388,500
-105,491
-21% -$189K ﹤0.01% 1919
2021
Q3 		$1.08M Sell
493,991
-1,011,300
-67% -$2.76M ﹤0.01% 1577
2021
Q2 		$5.64M Buy
1,505,291
+174,700
+13% +$607K 0.01% 806
2021
Q1 		$4.34M Buy
1,330,591
+35,500
+3% +$127K 0.01% 910
2020
Q4 		$4.42M Buy
1,295,091
+511,900
+65% +$2.11M 0.01% 874
2020
Q3 		$3.19M Buy
783,191
+72,600
+10% +$276K 0.01% 939
2020
Q2 		$2.4M Buy
710,591
+171,200
+32% +$499K 0.01% 1117
2020
Q1 		$1.26M Buy
539,391
+432,100
+403% +$1.18M ﹤0.01% 1357
2019
Q4 		$391K Sell
107,291
-19,500
-15% -$158K ﹤0.01% 1972
2019
Q3 		$1.05M Buy
126,791
+2,500
+2% +$20.2K ﹤0.01% 1411
2019
Q2 		$1.07M Buy
124,291
+37,700
+44% +$337K ﹤0.01% 1482
2019
Q1 		$926K Buy
86,591
+31,091
+56% +$333K ﹤0.01% 1565
2018
Q4 		$486K Buy
55,500
+41,100
+285% +$524K ﹤0.01% 1787
2018
Q3 		$242K Buy
+14,400
New +$312K ﹤0.01% 2027
2018
Q2 		– Sell
-17,000
Closed -$274K – 2531
2018
Q1 		$274K Sell
17,000
-9,691
-36% -$192K ﹤0.01% 2048
2017
Q4 		$506K Sell
26,691
-66,700
-71% -$1.21M ﹤0.01% 1770
2017
Q3 		$1.31M Buy
93,391
+23,300
+33% +$211K ﹤0.01% 1393
2017
Q2 		$522K Sell
70,091
-21,200
-23% -$139K ﹤0.01% 1783
2017
Q1 		$593K Sell
91,291
-46,300
-34% -$259K ﹤0.01% 1820
2016
Q4 		$610K Buy
137,591
+1,300
+1% +$5.45K ﹤0.01% 1761
2016
Q3 		$636K Buy
136,291
+84,600
+164% +$501K ﹤0.01% 1565
2016
Q2 		$340K Buy
51,691
+32,891
+175% +$232K ﹤0.01% 1669
2016
Q1 		$120K Buy
18,800
+8,000
+74% +$41K ﹤0.01% 1911
2015
Q4 		$65K Sell
10,800
-20,991
-66% -$120K ﹤0.01% 1802
2015
Q3 		$199K Buy
31,791
+9,299
+41% +$64.6K ﹤0.01% 1643
2015
Q2 		$154K Buy
+22,492
New +$143K ﹤0.01% 1781

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Advisers's SPPI Position: Q3 2022 in Review

Two Sigma Advisers sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 48,300 shares — an estimated $38K sold.

Two Sigma Advisers first reported a position in SPPI in Q2 2015 and held it in 28 quarters. The position peaked at $5.64M in Q2 2021. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.

  • Two Sigma Advisers reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 48,300 Spectrum Pharmaceuticals Inc shares in Q3 2022, an estimated $38K.
  • Two Sigma Advisers first reported a position in Spectrum Pharmaceuticals Inc in Q2 2015 and held it in 28 quarters.
  • Two Sigma Advisers's Spectrum Pharmaceuticals Inc position peaked at $5.64M in Q2 2021.
  • 75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.